Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
PLAYSTUDIOS Inc
MYPS
$78.6M
| $236K | ﹤0.01% |
245,110
-22,346
| -8% | -$24.1K |
|
4152
Kingstone Companies
KINS
$292M
| $236K | ﹤0.01% |
16,047
-4,126
| -20% | -$60.5K |
|
4153
Biote Corp
BTMD
$68.2M
| $235K | ﹤0.01% |
78,494
-8,572
| -10% | -$30.6K |
|
4154
Aclaris Therapeutics
ACRS
$729M
| $235K | ﹤0.01% |
123,425
-32,912
| -21% | -$57.4K |
|
|
MSTU
4155
T-Rex 2X Long MSTR Daily Target ETF
MSTU
$330M
| $233K | ﹤0.01% |
+5,020
| New | +$343K |
|
|
MSTU
4156
PUT
T-Rex 2X Long MSTR Daily Target ETF
MSTU
$330M
| $233K | ﹤0.01% |
+5,020
| New | +$343K |
|
4157
Energy Services of America
ESOA
$270M
| $233K | ﹤0.01% |
22,543
-982
| -4% | -$9.91K |
|
4158
iShares S&P 100 ETF
OEF
$20.1B
| $233K | ﹤0.01% |
700
| – | – |
|
4159
Expensify
EXFY
$173M
| $232K | ﹤0.01% |
125,609
-20,406
| -14% | -$41.3K |
|
4160
OP Bancorp
OPBK
$232M
| $231K | ﹤0.01% |
16,622
-4,216
| -20% | -$58.3K |
|
4161
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
| $230K | ﹤0.01% |
4,000
| – | – |
|
4162
OmniAb
OABI
$286M
| $230K | ﹤0.01% |
143,710
-37,967
| -21% | -$69.4K |
|
4163
Evolution Petroleum
EPM
$130M
| $230K | ﹤0.01% |
47,618
-11,275
| -19% | -$56.2K |
|
|
WBI
4164
WaterBridge Infrastructure LLC
WBI
$1.63B
| $230K | ﹤0.01% |
+9,100
| New | +$213K |
|
4165
ROBO Global Robotics & Automation Index ETF
ROBO
$1.96B
| $229K | ﹤0.01% |
3,500
| – | – |
|
4166
Larimar Therapeutics
LRMR
$394M
| $229K | ﹤0.01% |
70,893
-13,967
| -16% | -$52.4K |
|
4167
Mistras Group
MG
$486M
| $228K | ﹤0.01% |
23,208
-6,316
| -21% | -$56.2K |
|
|
GNTY
4168
DELISTED
Guaranty Bancshares
GNTY
| $228K | ﹤0.01% |
28,433
-1,037
| -4% | -$48.6K |
|
4169
Dynagas LNG Partners
DLNG
$134M
| $227K | ﹤0.01% |
64,800
| – | – |
|
4170
Protalix BioTherapeutics
PLX
$187M
| $226K | ﹤0.01% |
101,798
-25,165
| -20% | -$41K |
|
4171
Barnes & Noble Education
BNED
$430M
| $226K | ﹤0.01% |
22,700
-2,421
| -10% | -$22.6K |
|
|
ALMU
4172
Aeluma Inc
ALMU
$296M
| $224K | ﹤0.01% |
13,907
-47,938
| -78% | -$897K |
|
4173
Universal Logistics Holdings
ULH
$355M
| $224K | ﹤0.01% |
9,538
-3,426
| -26% | -$86.4K |
|
|
JMIA
4174
Jumia Technologies
JMIA
$739M
| $221K | ﹤0.01% |
19,000
-1,203
| -6% | -$8.8K |
|
4175
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
$157M
| $220K | ﹤0.01% |
5,609
-156
| -3% | -$6.05K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.